Encision Inc. (OTC Pink: ECIA) completed an $80,000 private placement with members of its board of directors, providing the Boulder,... Read More
The post Encision Raises $80,000 From Directors to Support Working Capital appeared first on citybiz.
The Akkermansia Company (TAC), a subsidiary of Danone and a pioneer in next-generation microbiome science, today announced a series of... Read More
The post Recent Patent and Court Developments in the U.S. and Europe Reinforce Danone’s Patent Position as Global Commercialization of Akkermansia MucT® Expands appeared first on citybiz.
LifeCare Home Health & Hospice Family has named Dr. Nasser Khan president and chief operating officer, adding an executive with... Read More
The post LifeCare Home Health & Hospice Names Nasser Khan President and COO appeared first on citybiz.
Inspiren has raised $70 million in Series C funding at a valuation exceeding $500 million, giving the senior living technology... Read More
The post Inspiren Raises $70 Million Series C at $500 Million-Plus Valuation appeared first on citybiz.
Cerenome Inc. has secured a senior secured financing facility of up to $20 million from 3i, LP, giving the Houston-based... Read More
The post Cerenome Secures Up to $20 Million to Scale CNSide Diagnostics appeared first on citybiz.
Ride Therapeutics has secured a commitment of up to $7.3 million from the Cystic Fibrosis Foundation to advance technology for... Read More
The post Ride Therapeutics Secures Up to $7.3 Million From Cystic Fibrosis Foundation appeared first on citybiz.
SCYNEXIS, Inc. (NASDAQ: SCYX) has appointed Sanjay Subramanian as chief financial officer, bringing in a biotechnology executive with more than... Read More
The post SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline appeared first on citybiz.
Candel Therapeutics, Inc. (Nasdaq: CADL) has appointed pharmaceutical regulatory executive Martine Zimmermann, PharmD, to its board of directors as the... Read More
The post Candel Therapeutics Adds Martine Zimmermann to Board Ahead of Planned BLA Filing appeared first on citybiz.
Retension Pharmaceuticals has appointed LeAnne Bloedon as executive vice president of clinical development and operations and Kevin Schutz as vice... Read More
The post Retension Pharmaceuticals Appoints LeAnne Bloedon and Kevin Schutz as Clinical and Regulatory Leaders appeared first on citybiz.
Vheda Health has secured a $47 million investment from healthcare-focused private equity firm Agora, giving the Columbia, Maryland-based outcomes and... Read More
The post Vheda Health Secures $47 Million Investment From Agora for National Expansion appeared first on citybiz.
Maryland health officials and state auditors are at odds over $6.4 million in Medicaid payments made on behalf of incarcerated... Read More
The post Maryland Health Officials, Auditors Clash Over $6.4 Million in Medicaid Payments appeared first on citybiz.
Encoded Therapeutics has raised $275 million in Series F financing to advance its lead genetic medicine ETX101 through pivotal development... Read More
The post Encoded Therapeutics Raises $275M to Advance ETX101 Through Pivotal Development appeared first on citybiz.
ImmunoGenesis has appointed Reza Mazhari, Ph.D., and Mike Davis to its board of directors as the clinical-stage biotechnology company advances... Read More
The post ImmunoGenesis Adds Reza Mazhari and Mike Davis to Board of Directors appeared first on citybiz.
Neurent Medical has secured a €25 million growth debt facility from Claret Capital Partners, adding non-equity capital to support the... Read More
The post Neurent Medical Secures €25 Million Growth Debt From Claret Capital Partners appeared first on citybiz.
H1 has acquired Defacto Health, a healthcare data company specializing in provider network intelligence, bringing a longtime data partner in-house... Read More
The post H1 Acquires Defacto Health to Expand Provider Network Intelligence appeared first on citybiz.
A cyberattack that disrupted systems and medical services at Luminis Health is putting renewed attention on the operational risks facing... Read More
The post Luminis Health Cyberattack Highlights Rising Threat to Healthcare Systems appeared first on citybiz.
Tortugas Neuroscience has appointed Amylyx Pharmaceuticals CFO Jim Frates to its board of directors and named him chair of the... Read More
The post Tortugas Neuroscience Adds Amylyx CFO Jim Frates to Board appeared first on citybiz.
Implicity has raised $40 million in growth equity funding led by European technology investor IRIS alongside Five Arrows, giving the... Read More
The post Implicity Raises $40 Million to Expand AI Cardiac Monitoring Platform appeared first on citybiz.
Clearway Health has appointed healthcare executive Rishi Seth as chief operating officer, adding a veteran of Millennium Physician Group, Optum... Read More
The post Clearway Health Names Rishi Seth COO to Scale Specialty Pharmacy Operations appeared first on citybiz.
Albaron Partners has completed the sale of Prime Psychiatry, a Texas-based provider of outpatient and interventional psychiatric services, to Beacon... Read More
The post Albaron Partners Sells Prime Psychiatry to Beacon Behavioral Partners appeared first on citybiz.
Latus Bio has appointed biotechnology and pharmaceutical veteran Donald Hayden, M.B.A., as chairman of its board of directors and former... Read More
The post Latus Bio Names Donald Hayden Chairman, Adds Michael MacLean to Board appeared first on citybiz.
Prilenia Therapeutics has appointed veteran neurologist and biopharmaceutical executive Frederick “Rick” E. Munschauer III, MD, MSc, FAAN, as chief medical... Read More
The post Prilenia Appoints Rick Munschauer Chief Medical Officer Ahead of Phase 3 Trials appeared first on citybiz.
Pyxis Oncology, Inc. (Nasdaq: PYXS) has appointed Thomas Civik as chief executive officer and chairman of the board, formalizing a... Read More
The post Pyxis Oncology Names Thomas Civik CEO and Chairman Ahead of MICVO Milestones appeared first on citybiz.
Concentra has appointed Tanner Newton executive vice president and chief financial officer, effective Nov. 1, 2026, advancing an internal executive... Read More
The post Concentra Names Tanner Newton Chief Financial Officer appeared first on citybiz.
IVI RMA North America has added reproductive endocrinologist and infertility specialist Dr. Blake Vessa to its RMA New Jersey care... Read More
The post RMA New Jersey Adds Reproductive Endocrinologist Dr. Blake Vessa appeared first on citybiz.
Rose BioSolutions has appointed biotechnology manufacturing veteran David Enloe as chief executive officer, bringing in an executive with more than... Read More
The post Rose BioSolutions Names David Enloe CEO to Scale Cell and Gene Therapy Platform appeared first on citybiz.
Editas Medicine, Inc. (Nasdaq: EDIT) has appointed Dan Ory, M.D., as Chief Medical Officer, adding an executive with more than... Read More
The post Editas Medicine Appoints Dan Ory as Chief Medical Officer appeared first on citybiz.
Central Ohio Urology Group has added Max S. Yudovich, M.D., to its care team, bringing the Columbus-area native back to... Read More
The post Max Yudovich Joins Central Ohio Urology Group appeared first on citybiz.
Teleflex Incorporated (NYSE: TFX) has appointed veteran medical technology executive Sean M. Salmon to its board of directors, effective September... Read More
The post Teleflex Appoints Medtronic Veteran Sean Salmon to Board of Directors appeared first on citybiz.
NovaBridge Biosciences (Nasdaq: NBP) has appointed veteran healthcare executive Martin Dewhurst to its Board of Directors as an independent director,... Read More
The post NovaBridge Appoints Martin Dewhurst as Independent Director appeared first on citybiz.
United Therapeutics Corporation (Nasdaq: UTHR) will repurchase approximately $477.6 million of its common stock through an accelerated share repurchase agreement... Read More
The post United Therapeutics to Complete $2 Billion Buyback With $477.6M ASR appeared first on citybiz.
Intellia Therapeutics (Nasdaq: NTLA) has secured a senior secured term loan facility of up to $400 million from OrbiMed, giving... Read More
The post Intellia Therapeutics Secures Up to $400 Million OrbiMed Debt Facility appeared first on citybiz.
Azenta, Inc. (Nasdaq: AZTA) has received full early repayment of a $35 million secured vendor loan tied to its sale... Read More
The post Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale appeared first on citybiz.
Pillar Biosciences has appointed Illumina executive Todd Christian and ORI Capital partner Yann Echelard, Ph.D., to its board of directors... Read More
The post Pillar Biosciences Adds Illumina and ORI Capital Executives to Board appeared first on citybiz.
CytoSorbents Corporation (Nasdaq: CTSO) will implement a 1-for-20 reverse stock split of its common shares, a step designed in part... Read More
The post CytoSorbents Plans 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing appeared first on citybiz.
Emergent BioSolutions Inc. (NYSE: EBS) has repurchased $75 million in principal amount of its senior unsecured notes due in 2028,... Read More
The post Emergent BioSolutions Repurchases $75 Million of Debt at Discount appeared first on citybiz.
Superluminal Medicines has raised an oversubscribed $60 million Series B financing to advance its lead obesity drug into clinical development... Read More
The post Superluminal Medicines Raises $60 Million to Advance Obesity Drug Into Clinic appeared first on citybiz.
Definitive Healthcare Corp. has received a non-binding proposal from Advent International to acquire the healthcare data and analytics company in... Read More
The post Definitive Healthcare Receives $1.02-Per-Share Going-Private Proposal From Advent appeared first on citybiz.
H.I.G. Capital has acquired Outcomes One, an Orlando, Florida-based provider of clinical network services and pharmacy technology that connects pharmacies... Read More
The post H.I.G. Capital Acquires Pharmacy Technology Provider Outcomes appeared first on citybiz.
Monarch has expanded its national network of membership-based women’s health practices into Texas with the launch of Lotus Gynecology in... Read More
The post Monarch Expands to Austin With Launch of Lotus Gynecology appeared first on citybiz.
Piedmont Orthopedics | OrthoAtlanta has added Bruce M. Byrd, MD, a board-certified orthopedic surgeon specializing in hip and knee replacement,... Read More
The post Piedmont Orthopedics | OrthoAtlanta Adds Joint Replacement Surgeon Bruce Byrd in Macon appeared first on citybiz.
Typewriter Therapeutics has emerged from stealth with $56 million in Series A financing to advance an RNA-based gene insertion platform... Read More
The post Typewriter Therapeutics Raises $56 Million Series A for In Vivo CAR T Platform appeared first on citybiz.
Boston-based Elucid has raised $55 million in an oversubscribed Series D financing to further commercialize its AI-powered cardiovascular imaging platform... Read More
The post Elucid Raises $55M Series D to Expand AI Platform for Heart Care appeared first on citybiz.
New York-based Norbert Health has raised $14 million in a Series A financing round backed by William A. Marino of... Read More
The post Norbert Health Raises $14M to Advance AI-Powered Nursing Robots appeared first on citybiz.
N-Power Medicine has raised $32 million in Series B funding as it pushes to expand a community oncology research network... Read More
The post N-Power Medicine Secures $32M to Push Community Oncology Research appeared first on citybiz.
BioMarin Pharmaceutical Inc. has completed its previously announced acquisition of Alesta Therapeutics, adding clinical-stage drug candidate ALE1 to its portfolio... Read More
The post BioMarin Completes Alesta Therapeutics Acquisition, Adding HPP Drug Candidate ALE1 appeared first on citybiz.
Enovis Corporation has entered into a binding offer to acquire French surgical robotics developer eCential Robotics at an upfront enterprise... Read More
The post Enovis Offers €155M to Acquire Surgical Robotics Developer eCential Robotics appeared first on citybiz.
OncoC4 has appointed Steve Chen, JD, PhD, general counsel, adding an executive with biotechnology, intellectual property and scientific experience as... Read More
The post OncoC4 Names Steve Chen General Counsel as Clinical Pipeline Advances appeared first on citybiz.
Immunic has appointed Chitrang Davé chief data and digital officer, creating a new C-suite role as the late-stage biotechnology company... Read More
The post Immunic Names Chitrang Davé Data and Digital Chief Ahead of Phase 3 Readout appeared first on citybiz.
NYU Langone Health has named William Gordon Frankle, MD, MBA, chair of the Department of Psychiatry at NYU Grossman School... Read More
The post NYU Langone Names William Gordon Frankle Chair of Psychiatry appeared first on citybiz.
Vertex Pharmaceuticals has completed its approximately $10 billion acquisition of Crinetics Pharmaceuticals, adding a commercial endocrine therapy and late-stage clinical... Read More
The post Vertex Completes $10 Billion Crinetics Acquisition, Expands Executive Leadership Team appeared first on citybiz.
CareReview has appointed Adam Schilling as Chief Growth Officer, adding an executive with more than 20 years of healthcare commercial... Read More
The post CareReview Names Adam Schilling Chief Growth Officer Amid Healthcare Expansion appeared first on citybiz.
Senticell has closed an oversubscribed seed financing round approaching $7 million to fund clinical studies of its red blood cell-based... Read More
The post Senticell Raises Nearly $7 Million to Advance RBC Liquid Biopsy Platform appeared first on citybiz.
Polaryx Therapeutics, Inc. (Nasdaq: PLYX) has appointed Will Charlton, M.D., M.A.S., as chief medical officer, strengthening its clinical leadership as... Read More
The post Polaryx Therapeutics Names Will Charlton CMO Ahead of Phase 2 SOTERIA Trial appeared first on citybiz.
Samsara Vision has promoted Jason Herod to president and chief executive officer, placing its former chief commercial officer at the... Read More
The post Samsara Vision Promotes Jason Herod to President and CEO appeared first on citybiz.
TELA Bio, Inc. (NASDAQ: TELA) is cutting approximately $17 million in annual operating expenses and reducing its workforce by about... Read More
The post TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs appeared first on citybiz.
Oligomerix has appointed biopharmaceutical industry veteran Dr. Cara Cassino as interim president and chief executive officer, bringing an experienced drug... Read More
The post Oligomerix Names Cara Cassino Interim CEO as Alzheimer’s Drug Advances appeared first on citybiz.
Transcat Inc. has acquired Southeastern Biomedical Associates Inc. for $12.8 million in cash, expanding its biomedical calibration, equipment repair and... Read More
The post Transcat Acquires Southeastern Biomedical for $12.8M to Expand Healthcare Services appeared first on citybiz.
ALLEGED FAULTY SOFTWARE TO BLAME FOR MULTI-MILLION DOLLAR MEDICAID FRAUD: Maryland is suing a former state health department contractor for its... Read More
The post State Roundup: Faulty Software To Blame For Millions In Medicaid Fraud; Dorchester Judge Promises Quick Decision In Second Redistricting Challenge; Updates On The Schools Blueprint appeared first on citybiz.
Virginia Cancer Specialists has added Kai-Li Liang, MD, a board-certified medical oncologist and clinical investigator, as the Northern Virginia cancer... Read More
The post Virginia Cancer Specialists Adds Oncologist Kai-Li Liang to Expand Clinical Research appeared first on citybiz.
BioXcel Therapeutics has entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH while... Read More
The post BioXcel Therapeutics Files Chapter 11, Agrees to Asset Sale With Teva appeared first on citybiz.
Quoin Pharmaceuticals Ltd. has entered into a private placement financing for up to approximately $50 million, providing the late clinical-stage... Read More
The post Quoin Pharmaceuticals Secures Up to $50 Million to Advance Rare Disease Pipeline appeared first on citybiz.
Metriport has raised $26 million in new funding in a round led by TJ Parker, a general partner at Matrix,... Read More
The post Metriport Secures $26M Led by Matrix to Aggregate Clinical Data appeared first on citybiz.
Slate Medicines has dosed the first participant in a Phase 1 clinical trial evaluating SLTE-1009, its experimental monoclonal antibody for... Read More
The post Slate Medicines Doses First Participant in Phase 1 Trial of Migraine Candidate SLTE-1009 appeared first on citybiz.
Hospitals manage an estimated $360 billion in purchased services ranging from food and laundry to maintenance and clinical engineering, yet... Read More
The post SpendRule Names Beth Graefe Strategic Advisor as Healthcare Payment Platform Expands appeared first on citybiz.
Psilera has appointed neuroscience drug development veteran Allyson Gage, PhD, as vice president of clinical development, putting her in charge... Read More
The post Psilera Names Allyson Gage Clinical Development VP Ahead of PSIL-006 Phase 1 Trial appeared first on citybiz.
Vascular Technology, Incorporated has appointed former Boston Scientific executive David Pierce to its board of directors, adding more than three... Read More
The post Vascular Technology Adds Former Boston Scientific Executive David Pierce to Board appeared first on citybiz.
Iylon Precision Oncology has appointed Mary Lopresti, D.O., chief medical officer, adding a board-certified medical oncologist and hematologist to its... Read More
The post Iylon Names Mary Lopresti Chief Medical Officer to Expand Precision Oncology Services appeared first on citybiz.
Rose BioSolutions has appointed Thomas VanCott, Ph.D., as head of HemaCare, its Cell Solutions business, adding a veteran cell therapy... Read More
The post Rose BioSolutions Names Thomas VanCott to Lead HemaCare Cell Solutions appeared first on citybiz.
Glucotrack, Inc. (Nasdaq: GCTK) will implement a 1-for-15 reverse stock split effective at the opening of trading Aug. 31, 2026,... Read More
The post Glucotrack Sets 1-for-15 Reverse Stock Split to Address Nasdaq Requirement appeared first on citybiz.
ProFound Therapeutics, a Cambridge, Massachusetts-based biotechnology company founded by Flagship Pioneering, has secured an investment commitment of up to $35... Read More
The post ProFound Therapeutics Secures Up to $35M From Gates Foundation for Maternal Health appeared first on citybiz.
Boston Scientific shares fell more than 2% in premarket trading Wednesday after the medical technology company disclosed a cybersecurity incident... Read More
The post Boston Scientific Shares Fall After Cyberattack Disrupts Global Operations appeared first on citybiz.
Mirai Bio has named Kate Torchilin, Ph.D., chief executive officer and president as the Cambridge, Massachusetts-based biotechnology company expands its... Read More
The post Mirai Bio Names Kate Torchilin CEO, Expands Leadership Team appeared first on citybiz.
Walden Media Group has been named agency of record for Stonegate Pharmacy, taking responsibility for growth marketing and go-to-market strategy... Read More
The post Walden Media Group Named Stonegate Pharmacy Agency of Record for U.S. Expansion appeared first on citybiz.
Airway Therapeutics has closed a $50 million equity financing round to fund late-stage development of zelpultide alfa, its lead biologic... Read More
The post Airway Therapeutics Raises $50 Million to Advance Zelpultide Alfa Clinical Program appeared first on citybiz.
Cleveland Diagnostics has appointed Valerie Dixon as Chief Financial Officer, adding a healthcare investment banking and strategic finance executive as... Read More
The post Cleveland Diagnostics Names Valerie Dixon CFO as IsoPSA Commercialization Expands appeared first on citybiz.
Madaket Health has appointed Varouzhan “V” Ebrahimian as Principal AI Architect and added Toni Osborne as Product Manager, expanding its... Read More
The post Madaket Health Expands AI and Product Teams to Modernize Provider Data Workflows appeared first on citybiz.
REGENXBIO Inc. (Nasdaq: RGNX) has appointed biotechnology investor Greg Ciongoli to its Board of Directors, effective August 25, 2026, as... Read More
The post REGENXBIO Adds Greg Ciongoli to Board Ahead of Commercial Expansion appeared first on citybiz.
McKesson Corporation (NYSE: MCK) has signed a definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion, expanding the... Read More
The post McKesson to Acquire Precision Medicine Group for $2.25 Billion appeared first on citybiz.
DrugScreens.com has appointed Molly McClure as fractional chief marketing officer, bringing back an early architect of the company’s brand to... Read More
The post DrugScreens.com Names Molly McClure Fractional CMO to Drive National Growth appeared first on citybiz.
Ekoscan Integrity Group has agreed to acquire Carestream Health’s U.S.-based non-destructive testing digital business, adding computed radiography and digital radiography... Read More
The post Ekoscan Integrity Group to Acquire Carestream’s U.S. NDT Digital Business appeared first on citybiz.
Testing whether a skincare compound can produce lasting biological effects has long faced a practical constraint: human skin removed from... Read More
The post Outer Bio Emerges From Stealth With Human Skin Testing Platform Yuna appeared first on citybiz.
FibroBiologics Inc. has appointed veteran sports agent Leigh Steinberg to its Board of Directors, adding a high-profile negotiator with longstanding... Read More
The post FibroBiologics Adds Sports Agent Leigh Steinberg to Board of Directors appeared first on citybiz.
Booz Allen Hamilton (NYSE: BAH) has completed its $720 million acquisition of Ultra I&C’s Mission Solutions business, expanding the company’s... Read More
The post Booz Allen Completes $720 Million Acquisition of Ultra Mission Solutions appeared first on citybiz.
Leerink Partners has appointed Chris McCarthy as senior managing director, adding a veteran healthcare sales executive to its Institutional Equities... Read More
The post Leerink Partners Adds Chris McCarthy to Expand Healthcare Equities Platform appeared first on citybiz.
Azenta Inc. has appointed board member Dr. Martin Madaus as interim president and CEO following the resignation of John Marotta,... Read More
The post Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance appeared first on citybiz.
Avista Healthcare Partners has named Tom Orr a Strategic Executive, adding an experienced medical device manufacturing operator to the private... Read More
The post Avista Healthcare Partners Adds Tom Orr as Strategic Executive appeared first on citybiz.
Austin, Texas-based Astromech, the AI company co-founded in 2025 by Colossal Biosciences CEO Ben Lamm and Harvard geneticist George Church,... Read More
The post Astromech $20M Funding Boosts Rise of Prediction-Focused AI in Life Sciences appeared first on citybiz.
Blair Street Advisors has invested in Kerno Inc., an inventory and operations software company serving businesses that manufacture physical products,... Read More
The post Blair Street Advisors Invests in Kerno as Thomas McKinney Becomes Chairman appeared first on citybiz.
AmeriHealth Caritas has made a strategic investment in Michigan-based Deon Health, providing growth capital to a specialty managed care company... Read More
The post AmeriHealth Caritas Invests in Deon Health to Expand Specialized Medicaid Care appeared first on citybiz.
NEXGEL, Inc. has appointed Brian Kieser interim chief executive officer and formed a board committee to conduct a strategic review... Read More
The post NEXGEL Names Brian Kieser Interim CEO, Launches Strategic Review appeared first on citybiz.
Werewolf Therapeutics and Ambros Therapeutics have entered into a definitive all-stock merger agreement that would create a Nasdaq-listed, late-stage biotechnology... Read More
The post Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing appeared first on citybiz.
Genentech plans to invest approximately $750 million in a new manufacturing facility at its Hillsboro, Oregon, campus, adding device fill-finish... Read More
The post Genentech Plans $750 Million Hillsboro Manufacturing Expansion for Drug Delivery Devices appeared first on citybiz.
Schweiger, a national dermatology and allergy care practice, has been named to the 2026 Inc. 5000 list of the fastest-growing... Read More
The post Schweiger Makes Inc. 5000 for 10th Consecutive Year as Practice Expands appeared first on citybiz.
Precision for Medicine has appointed Amanda Owens as general manager of Biospecimen Solutions, bringing an experienced life sciences executive into... Read More
The post Precision for Medicine Names Amanda Owens GM of Biospecimen Solutions appeared first on citybiz.
bioAffinity Technologies Inc. will implement a 1-for-15 reverse stock split effective at the opening of trading on August 24, 2026,... Read More
The post bioAffinity Technologies Sets 1-for-15 Reverse Stock Split for August 24 appeared first on citybiz.
Richmond, Va., maintained a steady showing on Inc.’s latest list of America’s fastest-growing private companies, with 19 businesses spanning healthcare... Read More
The post Tempo, Brandefy, Defiant Food Among 19 Richmond Companies on 2026 Inc. 5000 List appeared first on citybiz.
SFA Therapeutics Inc. has appointed Chairman Shawn Patrick O’Brien as CEO and realigned several senior leadership roles as the clinical-stage... Read More
The post SFA Therapeutics Names Shawn O’Brien CEO as Clinical Programs Advance appeared first on citybiz.
Specialty1 Partners has been named to the 2026 Inc. 5000 for the sixth consecutive year, extending a run on the... Read More
The post Specialty1 Partners Makes Inc. 5000 for Sixth Consecutive Year appeared first on citybiz.
Blooming Health has named Dr. Chethan Sathya chief public health officer in a fractional advisory capacity, expanding his relationship with... Read More
The post Blooming Health Names Dr. Chethan Sathya Chief Public Health Officer appeared first on citybiz.
